North America Diabetic Foot Ulcer Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-ischemic Ulcers), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care)
Market Introduction
The market growth in North America is attributed to rising prevalence of diabetic foot ulcers, rising incidence of diabetes and availability of advanced treatment for diabetic foot ulcer. The US dominates the market in 2020. In North America, the US is the largest market for diabetic foot ulcer. The growth of this market is primarily driven by increasing prevalence of diabetes in the US. The Centers for Disease Control and Prevention (CDC), in 2017, National Diabetes Statistics Report stated that nearly 23 million people in the US had diabetes, of which type 1 diabetes accounted for nearly 5% to 10%, or nearly 1.2 to 2.3 million people. Of people with type 2 diabetes, nearly 14%, or 3.2 million people, manage their diabetes with insulin only. Further, as per the American Podiatric Medical Association, Diabetes is the leading cause of lower extremity amputations in the US, and around 14-24% of patients with diabetes who develop foot ulcer will require an amputation. Availability of advanced treatment for diabetic foot ulcer is likely to enhance the market growth. For instance, in December 2017, the U.S. Food and Drug Administration approved the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers. The recent years have reported various joint ventures and collaborations to develop diabetic foot ulcer product in the US. For instance, in 2020, six US research institutions launched the first-ever multicenter network to study diabetic foot ulcers in the United States. This program is funded by the National Institutes of Health. So, above mentioned factor is expected to drive the market in the region.
In case of COVID-19, North America is highly affected specially the US. North America has been witnessing a growing number of COVID-19 cases since its outbreak. For instance, according to Worldometer, the number of cases increased to 33,321,244, with 593,148 deaths reported in the US as of May 06, 2021. The number of cases is also growing in Mexico and Canada. In Mexico, the cases have reached 2,355,985, with 218,007 deaths. The pandemic is straining public health systems globally, interrupting and delaying many kinds of critical health care. A recent survey by the World Health Organization found that health services are among the most frequently disrupted. 7 in 10 countries around the world are experiencing disruptions along with United states, Canada, and Mexico. However, as vaccines become available in 2021 the demand for wound care products is expected to increase. As treatment of chronic wounds like diabetic foot ulcer is essential for patients to ensure it is on the correct trajectory to heal, generally clinicians treat chronic wounds at least once a week to assess the progress of the wound. The American Medical Association has recommended to establish hospital-based outpatient wound center and home-based treatment options to manage and treat chronic wounds like diabetic foot ulcers. This is expected to increase the demand for treatment products that can be used at home as well as at outpatient centers. This is likely to favor the growth of diabetic foot ulcer treatment products.
Get more information on this report :
Market Overview and Dynamics
The North America diabetic foot ulcer treatment market is expected to grow from US$ 1,978.20 million in 2021 to US$ 3,428.51 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2021 to 2028. Chronic wounds such as diabetic foot ulcers often lead to complications, creating a challenge for surgeons to manage such injuries. With the significant increase in patient pool suffering from chronic wounds, the need for a systematic approach for the treatment has increased, which is encouraging the adoption of evidence-based treatment to make wound care effective. Several research and clinical trials related to chronic wounds management have demonstrated that bioactive wound care products improve the healing of moist wounds more effectively than the traditional wound care products. The active participation of government bodies and research organizations is promoting advancements in the wound care treatments. In December 2018, ConvaTec, a wound care specialist, collaborated with Academic Health Science Networks (AHSN) and the National Health Service (NHS) to improve wound care management. So, growing research activities to introduce novel wound treatment products will drive the market in coming years.
Key Market Segments
In terms of type, the advanced wound care dressings segment accounted for the largest share of the North America diabetic foot ulcer treatment market in 2020. In terms of ulcer type, the neuro-ischemic ulcers segment held a larger market share of the North America diabetic foot ulcer treatment market in 2020. Further, the hospitals segment held a larger share of the North America diabetic foot ulcer treatment market based on end user in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the North America diabetic foot ulcer treatment market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are 3M; B. Braun Melsungen AG; Cardinal Health Inc; Coloplast Group; ConvaTec Group Plc; Kerecis; Medline Industries, Inc.; MiMedx; Mölnlycke Health Care AB.; Organogenesis Inc.; Smith & Nephew; and URGO.
Reasons to buy report
- To understand the North America diabetic foot ulcer treatment market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America diabetic foot ulcer treatment market
- Efficiently plan M&A and partnership deals in North America diabetic foot ulcer treatment market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America diabetic foot ulcer treatment market
- Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.
North America Diabetic Foot Ulcer Treatment Market Segmentation
North America Diabetic Foot Ulcer Treatment Market - By Type
- Advanced Wound Care Dressings
- Hydrogel Dressings
- Collagen Dressing
- Alginate Dressings
- Foam Dressings
- Hydrocolloid Dressings
- Others
- Biologics
- Skin Grafts
- Growth Factors
- Therapy Device
- Negative Pressure Wound Therapy
- Ultrasound Therapy
North America Diabetic Foot Ulcer Treatment Market - By Ulcer Type
- Neuropathic Ulcers
- Ischemic Ulcers
- Neuro-ischemic Ulcers
North America Diabetic Foot Ulcer Treatment Market - By End User
- Hospitals
- Ambulatory Surgery Centers
- Home Care
North America Diabetic Foot Ulcer Treatment Market - By Country
- US
- Canada
- Mexico
North America Diabetic Foot Ulcer Treatment Market - Company Profiles
- 3M
- B. Braun Melsungen AG
- Cardinal Health Inc
- Coloplast Group
- ConvaTec Group Plc
- Kerecis
- Medline Industries, Inc.
- MiMedx
- Mölnlycke Health Care AB.
- Organogenesis Inc.
- Smith & Nephew
- URGO
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Diabetic Foot Ulcer Treatment Market – By Type
1.3.2 North America Diabetic Foot Ulcer Treatment Market – By Ulcer Type
1.3.3 North America Diabetic Foot Ulcer Treatment Market – By End User
1.3.4 North America Diabetic Foot Ulcer Treatment Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Diabetic Foot Ulcer Treatment Market– Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinion
5. North America Diabetic Foot Ulcer Treatment Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Diabetes and Related Chronic Wounds
5.1.2 Increase in the Geriatric Population
5.2 Key Market Restraints
5.2.1 Overpriced Advanced Wound Care Treatments
5.3 Key Market Opportunities
5.3.1 Growing Research Activities to Introduce Novel Wound Treatment Products
5.4 Future Trends
5.4.1 Surging Use of 3D Printing in Wound Care Management
5.5 Impact Analysis
6. Diabetic Foot Ulcer Treatment Market – North America Analysis
6.1 North America Diabetic Foot Ulcer Treatment Marker Revenue Forecast and Analysis
7. North America Diabetic Foot Ulcer Treatment Market Analysis – By Type
7.1 Overview
7.2 North America Diabetic Foot Ulcer Treatment Market Revenue Share, by Type (2020 and 2028)
7.3 Advanced Wound Care Dressings
7.3.1 Overview
7.3.2 Advanced Wound Care Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.3.3 Alginate Dressings
7.3.3.1 Overview
7.3.3.2 Alginate Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.3.4 Hydrogel Dressings
7.3.4.1 Overview
7.3.4.2 Hydrogel Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.3.5 Foam Dressings
7.3.5.1 Overview
7.3.5.2 Foam Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.3.6 Collagen Dressing
7.3.6.1 Overview
7.3.6.2 Collagen Dressing: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.3.7 Hydrocolloids Dressing
7.3.7.1 Overview
7.3.7.2 Hydrocolloids Dressing: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.3.8 Other Dressing
7.3.8.1 Overview
7.3.8.2 Other Dressing: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Biologics
7.4.1 Overview
7.4.2 Biologics: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.4.3 Growth Factors
7.4.3.1 Overview
7.4.3.2 Growth Factors: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.4.4 Skin Graft
7.4.4.1 Overview
7.4.4.2 Skin Graft: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.5 Therapy Device
7.5.1 Overview
7.5.2 Therapy Device: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.5.3 Negative Pressure Wound Therapy
7.5.3.1 Overview
7.5.3.2 Negative Pressure Wound Therapy: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
7.5.4 Ultrasound therapy
7.5.4.1 Overview
7.5.4.2 Ultrasound therapy: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
8. North America Diabetic Foot Ulcer Treatment Market Analysis – By Ulcer Type
8.1 Overview
8.2 North America Diabetic Foot Ulcer Treatment Market Revenue Share, by Ulcer Type (2020 and 2028)
8.3 Neuropathic Ulcers
8.3.1 Overview
8.3.2 Neuropathic Ulcers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Ischemic Ulcers
8.4.1 Overview
8.4.2 Ischemic Ulcers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
8.5 Neuro-ischemic Ulcers
8.5.1 Overview
8.5.2 Neuro-ischemic Ulcers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
9. North America Diabetic Foot Ulcer Treatment Market– By End User
9.1 Overview
9.2 North America Diabetic Foot Ulcer Treatment Market Revenue Share, by End User (2020 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
9.5 Home Care
9.5.1 Overview
9.5.2 Home Care: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
10. North America Diabetic Foot Ulcer Treatment Market – Country Analysis
10.1 North America: Diabetic Foot Ulcer Market
10.1.1 Overview
10.1.3 North America: Diabetic Foot Ulcer Market, by Country, 2020 & 2028 (%)
10.1.3.1 US: Diabetic Foot Ulcer Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.1.1 US: Diabetic Foot Ulcer Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.1.2 US: Diabetic Foot Ulcer Market, by Type, 2019–2028 (USD Million)
10.1.3.1.2.1 US Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2028 (USD Million)
10.1.3.1.2.2 US Diabetic Foot Ulcer Treatment Market, by Biologics – Revenue and Forecast to 2028 (USD Million)
10.1.3.1.2.3 US Diabetic Foot Ulcer Treatment Market, by Therapy Device – Revenue and Forecast to 2028 (USD Million)
10.1.3.1.3 US: Diabetic Foot Ulcer Market, by Ulcer Type, 2019–2028 (USD Million)
10.1.3.1.4 US: Diabetic Foot Ulcer Market, by End User, 2019–2028 (USD Million)
10.1.3.2 Canada: Diabetic Foot Ulcer Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.2.1 Canada: Diabetic Foot Ulcer Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.2.2 Canada: Diabetic Foot Ulcer Market, by Type, 2019–2028 (USD Million)
10.1.3.2.2.1 Canada Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2028 (USD Million)
10.1.3.2.2.2 Canada Diabetic Foot Ulcer Treatment Market, by Biologics – Revenue and Forecast to 2028 (USD Million)
10.1.3.2.2.3 Canada Diabetic Foot Ulcer Treatment Market, by Therapy Device – Revenue and Forecast to 2028 (USD Million)
10.1.3.2.3 Canada: Diabetic Foot Ulcer Market, by Ulcer Type, 2019–2028 (USD Million)
10.1.3.2.4 Canada: Diabetic Foot Ulcer Market, by End User, 2019–2028 (USD Million)
10.1.3.3 Mexico: Diabetic Foot Ulcer Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.3.1 Mexico: Diabetic Foot Ulcer Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.3.2 Mexico: Diabetic Foot Ulcer Market, by Type, 2019–2028 (USD Million)
10.1.3.3.2.1 Mexico Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2028 (USD Million)
10.1.3.3.2.2 Mexico Diabetic Foot Ulcer Treatment Market, by Biologics – Revenue and Forecast to 2028 (USD Million)
10.1.3.3.2.3 Mexico Diabetic Foot Ulcer Treatment Market, by Therapy Device – Revenue and Forecast to 2028 (USD Million)
10.1.3.3.3 Mexico: Diabetic Foot Ulcer Market, by Ulcer Type, 2019–2028 (USD Million)
10.1.3.3.4 Mexico: Diabetic Foot Ulcer Market, by End User, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on North America Diabetic Foot Ulcer Treatment Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 ConvaTec Group Plc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 3M
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Coloplast Group
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Smith & Nephew
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 B. Braun Melsungen AG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Medline Industries, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Cardinal Health Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Organogenesis Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Mölnlycke Health Care AB.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 MiMedx
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 URGO
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Kerecis
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Diabetic Foot Ulcer Treatment Market – Revenue, and Forecast to 2028 (US$ Million)
Table 2. US Diabetic Foot Ulcer Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. US Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2028 (USD Million)
Table 4. US Diabetic Foot Ulcer Treatment Market, by Biologics – Revenue and Forecast to 2028 (USD Million)
Table 5. US Diabetic Foot Ulcer Treatment Market, by Therapy Device – Revenue and Forecast to 2028 (USD Million)
Table 6. US Diabetic Foot Ulcer Market, by Ulcer Type – Revenue and Forecast to 2028 (USD Million)
Table 7. US Diabetic Foot Ulcer Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Diabetic Foot Ulcer Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Diabetic Foot Ulcer Treatment Market, by Biologics – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Diabetic Foot Ulcer Treatment Market, by Therapy Device – Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Diabetic Foot Ulcer Market, by Ulcer Type – Revenue and Forecast to 2028 (USD Million)
Table 13. Canada Diabetic Foot Ulcer Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Diabetic Foot Ulcer Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Diabetic Foot Ulcer Treatment Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Diabetic Foot Ulcer Treatment Market, by Biologics – Revenue and Forecast to 2028 (USD Million)
Table 17. Mexico Diabetic Foot Ulcer Treatment Market, by Therapy Device – Revenue and Forecast to 2028 (USD Million)
Table 18. Mexico Diabetic Foot Ulcer Market, by Ulcer Type – Revenue and Forecast to 2028 (USD Million)
Table 19. Mexico Diabetic Foot Ulcer Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 20. Organic Developments Done By Companies
Table 21. Inorganic Developments Done By Companies
Table 22. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Diabetic Foot Ulcer Treatment Market Segmentation
Figure 2. North America Diabetic Foot Ulcer Treatment Market – By Country
Figure 3. North America Diabetic Foot Ulcer Treatment Market Overview
Figure 4. Advanced Wound Care Dressings Segment Held Largest Share of North America Diabetic Foot Ulcer Treatment Market by Type
Figure 5. US to Show Significant Growth During Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Expert Opinion
Figure 8. North America Diabetic Foot Ulcer Treatment Market Impact Analysis of Driver and Restraints
Figure 9. North America Diabetic Foot Ulcer Treatment Market – Revenue Forecast and Analysis
Figure 10. North America Diabetic Foot Ulcer Treatment Market Revenue Share, by Type (2020 and 2028)
Figure 11. North America Advanced Wound Care Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. North America Alginate Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. North America Hydrogel Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Foam Dressings: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Collagen Dressing: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Hydrocolloids Dressing: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Other Dressing: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Biologics: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Growth Factors: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. North America Skin Graft: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America Therapy Device: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Negative Pressure Wound Therapy: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Ultrasound therapy: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 24. North America Diabetic Foot Ulcer Treatment Market Revenue Share, by Ulcer Type (2020 and 2028)
Figure 25. North America Neuropathic Ulcers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America Ischemic Ulcers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America Neuro-ischemic Ulcers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America Diabetic Foot Ulcer Treatment Market Revenue Share, by End User (2020 and 2028)
Figure 29. North America Hospitals: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 30. North America Ambulatory Surgical Centers: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. North America Home Care: Diabetic Foot Ulcer Treatment Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. North America: Diabetic Foot Ulcer Market, by Key Country – Revenue (2020) (USD Million)
Figure 33. North America: Diabetic Foot Ulcer Market, by Country, 2020 & 2028 (%)
Figure 34. US: Diabetic Foot Ulcer Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Canada: Diabetic Foot Ulcer Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Mexico: Diabetic Foot Ulcer Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in North American Country Markets
- 3M
- B. Braun Melsungen AG
- Cardinal Health Inc
- Coloplast Group
- ConvaTec Group Plc
- Kerecis
- Medline Industries, Inc.
- MiMedx
- Mölnlycke Health Care AB.
- Organogenesis Inc.
- Smith & Nephew
- URGO
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America diabetic foot ulcer treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in North America diabetic foot ulcer treatment market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the diabetic foot ulcer treatment market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution